| Ident. | Authors (with country if any) | Title |
|---|
| 000056 (2013) |
Éric Thouvenot [France] ; William Camu [France] | Vitamine D et neurologie : Vitamine D |
| 000072 (2013) |
Jacques Poirier [France] | James Parkinson (1755-1824) revisité |
| 000081 (2013) |
E. Broussolle [France] ; J.-M. Trocello [France] ; F. Woimant [France] ; A. Lachaux [France] ; N. Quinn [Royaume-Uni] | Samuel Alexander Kinnier Wilson. Wilson's disease, Queen Square and neurology : Maladie de Wilson |
| 000118 (2012) |
| Passeur d'espérance, itinéraire d'un parkinsonien |
| 000466 (2010) |
T. A. Zesiewicz [États-Unis] ; K. L. Sullivan [États-Unis] ; I. Arnulf [France] ; K. R. Chaudhuri [Royaume-Uni] ; J. C. Morgan [États-Unis] ; G. S. Gronseth [États-Unis] ; J. Miyasaki [Canada] ; D. J. Iverson [États-Unis] ; W. J. Weiner [États-Unis] | Practice Parameter: Treatment of nonmotor symptoms of Parkinson disease: Report of the Quality Standards Subcommittee of the American Academy of Neurology |
| 000468 (2010) |
Anne S. Soehn [Allemagne] ; Thomas Franck [Allemagne] ; Saskia Biskup [Allemagne] ; Emilie Giaime [France] ; Christian Melle [Allemagne] ; Ruth Rott [Israël] ; Daniel Cebo [Allemagne] ; Hubert Kalbacher [Allemagne] ; Erwin Ott [Autriche] ; Jens Pahnke [Allemagne] ; Thomas Meitinger [Allemagne] ; Rejko Krüger [Allemagne] ; Thomas Gasser [Allemagne] ; Daniela Berg [Allemagne] ; Ferdinand Von Eggeling [Allemagne] ; Simone Engelender [Israël] ; Cristine Alves Da Costa [France] ; Olaf Riess [Allemagne] | Periphilin is a novel interactor of synphilin-1, a protein implicated in Parkinson's disease |
| 000506 (2010) |
Paul Krack [France] ; Marwan I. Hariz [Royaume-Uni, Suède] ; Christelle Baunez [France] ; Jorge Guridi [Espagne] ; Jose A. Obeso [Espagne] | Deep brain stimulation: from neurology to psychiatry? |
| 000587 (2009) |
Sébastien Montel [France] ; Anne-Marie Bonnet [France] ; Catherine Bungener [France] | Quality of Life in Relation to Mood, Coping Strategies, and Dyskinesia in Parkinson's Disease |
| 000650 (2009) |
Cécile Cazeneuve [France] ; Channkanira San [France] ; Salah A. Ibrahim [Soudan] ; Maowia M. Mukhtar [Soudan] ; Musa M. Kheir [Soudan] ; Eric Leguern [France] ; Alexis Brice [France] ; Mustafa A. Salih [Arabie saoudite] | A new complex homozygous large rearrangement of the PINK1 gene in a Sudanese family with early onset Parkinson's disease |
| 000654 (2009) |
C. Pirkevi [Turquie] ; S. Lesage [France] ; C. Condroyer [France] ; H. Tomiyama [Japon] ; N. Hattori [Japon] ; S. Ertan [Turquie] ; A. Brice [France] ; A. N. Basak [Turquie] | A LRRK2 G2019S mutation carrier from Turkey shares the Japanese haplotype |
| 000704 (2008) |
Gilles Orgeret [France] ; Thierry Gavardin [France] ; Guy Hoffmann | Apport de la Thérapie Normotensive dans le traitement de l'hémiplégie et de la maladie de Parkinson |
| 000783 (2008) |
Marek Szatanik [France] ; Nicolas Vibert [France] ; Isabelle Vassias [France] ; Jean-Louis Guenet [France] ; Daniel Eugene [France] ; Catherine De Waele [France] ; Jean Jaubert [France] | Behavioral effects of a deletion in Kcnn2, the gene encoding the SK2 subunit of small-conductance Ca2+-activated K+ channels |
| 000912 (2007) |
Anne Grünewald [Allemagne] ; Guido J. Breedveld [Pays-Bas] ; Katja Lohmann-Hedrich [Allemagne] ; Christan F. Rohe [Pays-Bas] ; Inke R. König [Allemagne] ; Johann Hagenah [Allemagne] ; Nicola Vanacore [Italie] ; Giuseppe Meco [Italie] ; Angelo Antonini [Italie] ; Stefano Goldwurm [Italie] ; Suzanne Lesage [France] ; Alexandra Dürr [France] ; Ferdinand Binkofski [Allemagne] ; Hartwig Siebner [Allemagne] ; Alexander Münchau [Allemagne] ; Alexis Brice [France] ; Ben A. Oostra [Pays-Bas] ; Christine Klein [Allemagne] ; Vincenzo Bonifati [Pays-Bas] | Biological effects of the PINK1 c.1366C>T mutation : implications in Parkinson disease pathogenesis |
| 000C00 (2004) |
Kay Castagnoli [États-Unis] ; Thangaraju Murugesan [États-Unis] | Tobacco leaf, smoke and smoking, MAO inhibitors, Parkinson's disease and neuroprotection; are there links? |
| 000C01 (2004) |
Moussa B. H. Youdim [Israël] ; Marta Weinstock [Israël] | Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation |
| 000C03 (2004) |
Michael A. Collins [États-Unis] | Tetrahydropapaveroline in Parkinson's disease and alcoholism: A look back in honor of Merton Sandler |
| 000C19 (2004) |
Toshiharu Nagatsu [Japon] | Progress in monoamine oxidase (MAO) research in relation to genetic engineering |
| 000C25 (2004) |
William J. Burke [États-Unis] ; SHU WEN LI [États-Unis] ; Hyung D. Chung [États-Unis] ; David A. Ruggiero [États-Unis] ; Bruce S. Kristal [États-Unis] ; Eugene M. Johnson [États-Unis] ; Patricia Lampe [États-Unis] ; Vijaya B. Kumar [États-Unis] ; Mark Franko [États-Unis] ; Evelyn A. Williams [États-Unis] ; Daniel S. Zahm [États-Unis] | Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: Role in neurodegenerative diseases |
| 000C28 (2004) |
Peter Riederer [Allemagne] ; Walter Danielczyk [Autriche] ; Edna Grünblatt [Allemagne] | Monoamine oxidase-B inhibition in Alzheimer's disease |
| 000C52 (2004) |
Makoto Naoi [Japon] ; Wakako Maruyama [Japon] ; Georgy M. Nagy [Hongrie] | Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: Occurrence, metabolism and function in human brains |
| 000C60 (2004) |
N. Hamaue [Japon] ; M. Minami [Japon] ; M. Terado [Japon] ; M. Hirafuji [Japon] ; T. Endo [Japon] ; M. Machida [Japon] ; T. Hiroshige [Japon] ; A. Ogata [Japon] ; K. Tashiro [Japon] ; H. Saito [Japon] ; S. H. Parvez [France] | Comparative study of the effects of isatin, an endogenous MAO-inhibitor, and selegiline on bradykinesia and dopamine levels in a rat model of Parkinson's disease induced by the Japanese encephalitis virus |
